133 related articles for article (PubMed ID: 24118113)
21. A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label study.
Ligthelm RJ; Gylvin T; DeLuzio T; Raskin P
Endocr Pract; 2011; 17(1):41-50. PubMed ID: 20713345
[TBL] [Abstract][Full Text] [Related]
22. [The predictive factors of good glycaemic control in Chinese patients receiving biphasic insulin as part 30: a subgroup analyses from the A1 chieve study].
Hong J; Lei M; Chang B; Gao Z; Wang Z; Zhang X; Zhuang X; Chen B; Xu M; Yang W
Zhonghua Nei Ke Za Zhi; 2015 Aug; 54(8):705-10. PubMed ID: 26674627
[TBL] [Abstract][Full Text] [Related]
23. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.
Kaneko S; Chow F; Choi DS; Taneda S; Hirao K; Park Y; Andersen TH; Gall MA; Christiansen JS;
Diabetes Res Clin Pract; 2015 Jan; 107(1):139-47. PubMed ID: 25498130
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
[TBL] [Abstract][Full Text] [Related]
25. Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results.
Nobels F; D'Hooge D; Crenier L
Curr Med Res Opin; 2012 Jun; 28(6):1017-26. PubMed ID: 22612579
[TBL] [Abstract][Full Text] [Related]
26. Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs: a subgroup analysis of the A₁chieve study.
Chen L; Xing X; Lei M; Liu J; Shi Y; Li P; Qin G; Li C; Li Y; Wang Q; Gao T; Hu L; Wang Y; Yang W
Chin Med J (Engl); 2014; 127(2):208-12. PubMed ID: 24438605
[TBL] [Abstract][Full Text] [Related]
27. The SimpleMix study with biphasic insulin aspart 30: a randomized controlled trial investigating patient-driven titration versus investigator-driven titration.
Gao Y; Luquez C; Lynggaard H; Andersen H; Saboo B
Curr Med Res Opin; 2014 Dec; 30(12):2483-92. PubMed ID: 25180608
[TBL] [Abstract][Full Text] [Related]
28. Initiating or switching to biphasic insulin aspart 30 in type 2 diabetes patients from Algeria: a sub-analysis of the A₁chieve study.
Lezzar A; Ayad F; Dahaoui A; Salah-Mansour A; Berrouiguet AY
Diabetes Res Clin Pract; 2013 Aug; 101 Suppl 1():S37-44. PubMed ID: 23958570
[TBL] [Abstract][Full Text] [Related]
29. Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Wang C; Mamza J; Idris I
Diabet Med; 2015 May; 32(5):585-94. PubMed ID: 25594251
[TBL] [Abstract][Full Text] [Related]
30. Switching from biphasic human insulin to biphasic insulin aspart 30 in type 2 diabetes: results from the ASEAN subgroup of the A₁chieve study.
Hussein Z; Lim-Abrahan MA; Jain AB; Goh SY; Soewondo P
Diabetes Res Clin Pract; 2013 Apr; 100 Suppl 1():S24-9. PubMed ID: 23647714
[TBL] [Abstract][Full Text] [Related]
31. Biphasic insulin aspart 30 in insulin-naive people with type 2 diabetes in non-western nations: results from a regional comparative multinational observational study (A(1)chieve).
Shah S; Yang W; Hasan MI; Malek R; Molskov Bech O; Home P
Diabetes Technol Ther; 2013 Nov; 15(11):954-63. PubMed ID: 24053450
[TBL] [Abstract][Full Text] [Related]
32. Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11).
Hirao K; Arai K; Yamauchi M; Takagi H; Kobayashi M;
Diabetes Res Clin Pract; 2008 Jan; 79(1):171-6. PubMed ID: 17919762
[TBL] [Abstract][Full Text] [Related]
33. Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification.
Malek R; Ajili F; Assaad-Khalil SH; Shinde A; Chen JW; Van den Berg E
Diabetes Metab; 2015 Jun; 41(3):223-30. PubMed ID: 25483023
[TBL] [Abstract][Full Text] [Related]
34. TREATMENT INTENSIFICATION WITH INSULIN DEGLUDEC/INSULIN ASPART TWICE DAILY: RANDOMIZED STUDY TO COMPARE SIMPLE AND STEP-WISE TITRATION ALGORITHMS.
Gerety G; Bebakar WM; Chaykin L; Ozkaya M; Macura S; Hersløv ML; Behnke T
Endocr Pract; 2016 May; 22(5):546-54. PubMed ID: 26720250
[TBL] [Abstract][Full Text] [Related]
35. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice.
Ligthelm RJ
Prim Care Diabetes; 2009 May; 3(2):97-102. PubMed ID: 19285933
[TBL] [Abstract][Full Text] [Related]
36. Influence of BMI, Age and duration of diabetes mellitus on glycaemic control with twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart (JDDM 18): retrospective reanalysis of a 6-month, randomized, open-label, multicentre trial in Japan.
Arai K; Hirao K; Yamauchi M; Takagi H; Kobayashi M;
Clin Drug Investig; 2010; 30(1):35-40. PubMed ID: 19995096
[TBL] [Abstract][Full Text] [Related]
37. Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.
Kann PH; Wascher T; Zackova V; Moeller J; Medding J; Szocs A; Mokan M; Mrevlje F; Regulski M
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):527-32. PubMed ID: 17115351
[TBL] [Abstract][Full Text] [Related]
38. Three different premixed combinations of biphasic insulin aspart - comparison of the efficacy and safety in a randomized controlled clinical trial in subjects with type 2 diabetes.
Cucinotta D; Smirnova O; Christiansen JS; Kanc K; le Devehat C; Wojciechowska M; López de la Torre M; Liebl A
Diabetes Obes Metab; 2009 Jul; 11(7):700-8. PubMed ID: 19476479
[TBL] [Abstract][Full Text] [Related]
39. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
[TBL] [Abstract][Full Text] [Related]
40. Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure.
Miyashita Y; Nishimura R; Nemoto M; Matsudaira T; Kurata H; Yokota T; Yokota K; Tojo K; Utsunomiya K; Tajima N
Cardiovasc Diabetol; 2008 May; 7():16. PubMed ID: 18507868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
